Pain

Latest News

Interictal Burden of Cluster Headache Greatly Affects Disease Burden and Quality of Life

Survey findings suggest that cluster headache attacks can negatively affect an individual’s career, education, and social life.

FDA Committees Vote on Novel Opioid for Chronic Low Back Pain

As a result of the vote, Nektar has decided to withdraw the New Drug Application for oxycodegol and to cease further development of the product.

ACHIEVE II Trial Finds Ubrogepant Superior to Placebo for Pain Freedom in Moderate, Severe Migraine

Acute treatment of migraine with ubrogepant, an oral calcitonin gene-related peptide antagonist, was superior to placebo for migraine pain freedom.

Nerve Volumes Predict Surgical Outcome in Patients With Trigeminal Neuralgia

Larger contralateral trigeminal nerve and hippocampus volumes are predictive of early nonresponse to surgical treatment of trigeminal neuralgia.

Closed-Loop Spinal Cord Stimulation for the Management of Chronic Back and Leg Pain [Part 1]

Spinal cord stimulation (SCS) with a closed-loop system that uses recorded evoked compound action potentials (ECAPs) is superior to a fixed-output, open-loop system for patients with chronic back and leg pain.

Acupuncture and Acupressure May Aid in Pain Management for Patients With Cancer

Researchers found the use of acupuncture and/or acupressure is associated with reduced cancer pain and decreased use of analgesics.

Migraine Aura Complexity Score Stratifies and Identifies Phenotypes of Migraine With Aura

The newly developed Migraine Aura Complexity Score is effective for stratifying patients with migraine with aura.

New Findings on Timing of Migraines After Poor Sleep

Researchers found that a poor night’s sleep may increase risk for migraine the following day, rather than the next morning.

Ubrogepant Approved for Acute Treatment of Migraine

The Food and Drug Administration (FDA) has approved Ubrelvy (ubrogepant tablets; Allergan), the first oral calcitonin gene-related peptide (CGRP) receptor antagonist, for the acute treatment of migraine with or without aura in adults.

Evidence Supports Use of High-Dose Aspirin for Migraine

Evidence supports the use of high-dose aspirin for treating acute migraine and low-dose aspirin for prevention of recurrent attacks.